Cubist Systematic Strategies’s Asensus Surgical, Inc. ASXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-11,119
Closed -$3K 4223
2023
Q3
$3K Buy
+11,119
New +$4.04K ﹤0.01% 3189
2022
Q3
Sell
-21,643
Closed -$9K 4833
2022
Q2
$9K Buy
+21,643
New +$9.66K ﹤0.01% 4279
2022
Q1
Sell
-38,690
Closed -$43K 3845
2021
Q4
$43K Buy
+38,690
New +$59.8K ﹤0.01% 3325
2021
Q3
Sell
-438,853
Closed -$1.39M 3237
2021
Q2
$1.39M Buy
438,853
+90,104
+26% +$225K 0.02% 1344
2021
Q1
$1.13M Buy
+348,749
New +$1.26M 0.01% 1460
2016
Q2
Sell
-1,414
Closed -$78K 1922
2016
Q1
$78K Buy
+1,414
New +$60.6K ﹤0.01% 1432

Other funds holding ASXC

Cubist Systematic Strategies's ASXC Position: Q4 2023 in Review

Cubist Systematic Strategies sold out of Asensus Surgical, Inc. (ASXC) in Q4 2023, closing a stake of 11,119 shares — an estimated $3K sold.

Cubist Systematic Strategies first reported a position in ASXC in Q1 2016 and held it in 6 quarters. The position peaked at $1.39M in Q2 2021. 73 funds tracked by Wall St. Rank hold ASXC as of Q4 2023.

  • Cubist Systematic Strategies reported no remaining Asensus Surgical, Inc. position as of Q4 2023 after selling out during the quarter.
  • Cubist Systematic Strategies sold 11,119 Asensus Surgical, Inc. shares in Q4 2023, an estimated $3K.
  • Cubist Systematic Strategies first reported a position in Asensus Surgical, Inc. in Q1 2016 and held it in 6 quarters.
  • Cubist Systematic Strategies's Asensus Surgical, Inc. position peaked at $1.39M in Q2 2021.
  • 73 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q4 2023.

Based on Cubist Systematic Strategies's 13F filing for Q4 2023, filed 14 Feb 2024.